Top Markets
#1 Black Phoenix Black Phoenix +743.63%
#2 Islamic Coin Islamic Coin +146.07%
#3 Beam Beam +32.83%
#4 THORChain THORChain +25.51%
#5 TENDIES TENDIES +19.49%
#6 THORChain Yield THORChain Yield +19.43%
#7 SAFEcoin SAFEcoin +18.45%
#8 MiL.k Alliance MiL.k Alliance +16.38%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +16.02%
#10 Bless Bless +15.60%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Classement en actions #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
Prix de l'action
$93.80
Dernière synchronisation: 2025-04-28
Capitalisation boursière
$2.68B
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Aerovate Therapeutics, Inc. (AVTE)

Catégorie

Healthcare
Ratio P/B pour Aerovate Therapeutics, Inc. (AVTE)
Ratio P/B au August 2026 TTM : 0.37
Selon les derniers rapports financiers et le cours de l'action de Aerovate Therapeutics, Inc., le ratio cours/valeur comptable actuel (TTM) est 0.37. À la fin de 2023, le ratio P/B était de 5.44.
Historique du ratio P/B pour Aerovate Therapeutics, Inc. de 2020 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
2026 (TTM) 0.37 -100.02%
2024 -1.62K -29,830.16%
2023 5.44 -3.77%
2022 5.66 238.93%
2021 1.67 -99.12%
2020 189.49 0.00%
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 1,605.27%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 1,578.22%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 897.23%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 573.68%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH